Jorge Garcia
豪尔赫·加西亚
MD, FACP
Professor of Medicine, Chair of Solid Tumor Oncology医学教授、实体瘤肿瘤科主任
👥Biography 个人简介
Jorge Garcia is a prominent GU oncologist at Cleveland Clinic leading clinical research in kidney and prostate cancer. He has contributed extensively to phase I-III trials of targeted therapies and immunotherapy combinations and serves as a leading voice in treatment guideline development for renal cell carcinoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Targeted Therapy Sequencing in RCC
Led clinical research establishing optimal sequencing strategies for targeted agents and immunotherapy combinations in metastatic renal cell carcinoma, improving outcomes for treatment-refractory patients.
Novel Agent Development
Conducted early-phase trials of multiple targeted agents in GU malignancies, contributing to approval of several therapies for kidney and prostate cancer through investigator-initiated and cooperative group studies.
Representative Works 代表性著作
Phase II Trial of Everolimus in Previously Treated Patients with Metastatic Renal Cell Carcinoma
Journal of Clinical Oncology (2010)
Contributed to mTOR inhibitor positioning in the RCC treatment algorithm after VEGF-targeted therapy failure.
Cabozantinib in Patients with Advanced Prostate Cancer
Journal of Clinical Oncology (2012)
Early-phase trial demonstrating promising bone and soft tissue responses with cabozantinib in metastatic CRPC.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Brian I. Rini
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Robert J. Motzer
Memorial Sloan Kettering Cancer Center
Toni K. Choueiri
Dana-Farber Cancer Institute, Harvard Medical School
Jonathan Rosenberg
Memorial Sloan Kettering Cancer Center
关注 豪尔赫·加西亚 的研究动态
Follow Jorge Garcia's research updates
留下邮箱，当我们发布与 Jorge Garcia（Cleveland Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment